Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
188P Impact of metformin, statin, aspirin and insulin on the prognosis of unresectable HCC patients receiving first-line lenvatinib or atezolizumab plus bevacizumab
M. Rimini, Elisabeth Amadeo, Francesco Vitiello, Silvia Foti, M. Persano, Toshifumi Tada, Goki Suda, S. Shimose, Masatoshi Kudo, Jaekyung Cheon, F. Finkelmeier, Ho Yeong Lim, F. Piscaglia, Gianluca Masi, Changhoon Yoo, S. Lonardi, Federico Rossari, Silvia Camera, A. Casadei Gardini, José Presa (2023). 188P Impact of metformin, statin, aspirin and insulin on the prognosis of unresectable HCC patients receiving first-line lenvatinib or atezolizumab plus bevacizumab. , 34, DOI: https://doi.org/10.1016/j.annonc.2023.10.767.
Article13 days ago165P BMI impact on the prognosis of unresectable HCC patients receiving first-line lenvatinib or atezolizumab plus bevacizumab
Elisabeth Amadeo, M. Persano, Toshifumi Tada, Goki Suda, S. Shimose, Masatoshi Kudo, Changhoon Yoo, Federico Rossari, Francesco Vitiello, A. Casadei Gardini, M. Rimini (2023). 165P BMI impact on the prognosis of unresectable HCC patients receiving first-line lenvatinib or atezolizumab plus bevacizumab. , 34, DOI: https://doi.org/10.1016/j.annonc.2023.10.300.
Article13 days ago185P Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study
Federico Rossari, Toshifumi Tada, S. Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, F. Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, F. Bergamo, Elisabeth Amadeo, Francesco Vitiello, Silvia Foti, M. Persano, F. Piscaglia, M. Scartozzi, S. Cascinu, M. Rimini, A. Casadei Gardini (2023). 185P Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study. , 34, DOI: https://doi.org/10.1016/j.annonc.2023.10.764.
Article13 days ago<scp>α‐FAtE</scp>: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Francesca Bergamo, Elisabeth Amadeo, Francesco Vitiello, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Massimo Iavarone, Giuseppe Cabibbo, Margarida Montes, Francesco Giuseppe Foschi, Caterina Vivaldi, Caterina Soldà, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Valentina Burgio, Fabio Piscaglia, Mario Scartozzi, Stefano Cascinu, Andrea Casadei‐Gardini, Margherita Rimini (2023). <scp>α‐FAtE</scp>: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma. , 154(6), DOI: https://doi.org/10.1002/ijc.34799.
Article13 days agoEfficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study
Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, Caterina Vivaldi, Masatoshi Kudo, Shigeo Shimose, Goki Suda, Silvia Camera, Silvia Foti, Mario Domenico Rizzato, Francesca Salani, Naoshi Nishida, Tomotake Shirono, Naoya Sakamoto, Laura Passeri, Michele Ferrara, Caterina Soldà, Silvia Cesario, Kazuomi Ueshima, Takashi Niizeki, Takuya Sho, Mara Persano, Francesco Vitiello, Federica Invernizzi, Sara Lonardi, Gianluca Masi, Margherita Rimini, Andrea Casadei‐Gardini (2025). Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study. , 56(3), DOI: https://doi.org/10.1111/hepr.70076.
Article13 days ago